Global DNA Sequencing

DNA Sequencing Comprehensive Study by Type (Consumable, Instrument, Service), Application (Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, Research, Treatment analysis), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single-Molecule Real-time Sequencing, Chain Termination Sequencing, Nanopore Sequencing), End User (Pharmaceutical Companies, Biotechnology Companies, Hospitals & Clinics, Academic & Government Research Institutes) Players and Region - Global Market Outlook to 2028

DNA Sequencing Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About DNA Sequencing
DNA sequencing is important to apply to the human genome. It allows scientists to sequence genes and genomes.DNA Sequencing market is expected to grow in the future due to the rising demand for easy and fast clinical diagnosis and an increase in cancer research activities. The surging trend of personalized genomics boosting the market.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)


The global market is highly competitive and consists of a limited number of providers who compete with each other. The intense competition, changing consumer spending patterns, demographic trends, and frequent changes in consumer preferences pose significant opportunities for market growth. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global DNA Sequencing market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Siemens AG (Germany), Pacific Biosciences of California, Inc. (United States), Eppendorf (Germany), PerkinElmer, Inc. (United States), Agilent Technologies, Inc. (United States), Illumina, Inc. (United States), LI-COR Biosciences, Inc (United States), Oxford Nanopore Technologies Limited (United Kingdom), F. Hoffmann-La Roche AG (Switzerland), ThermoFisher Scientific (United States) and Longas Technologies (Australia) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global DNA Sequencing market by Type (Consumable, Instrument and Service), Application (Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, Research and Treatment analysis) and Region.



On the basis of geography, the market of DNA Sequencing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Technology, the sub-segment i.e. Sequencing by Synthesis will boost the DNA Sequencing market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Pharmaceutical Companies will boost the DNA Sequencing market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Technological Advancements in DNA Sequencing

Market Growth Drivers:
Growing Demand for Easy and Fast Clinical Diagnosis and Increasing Number of Genome Mapping Programs

Challenges:
Dearth of Skilled Professionals

Restraints:
Standardization concerns over DNA Sequencing-based Diagnostics and Expensive Machinery

Opportunities:
Rising R & D Investment in DNA Sequencing and Surging Demand from Emerging Markets

Market Leaders and their expansionary development strategies
In May 2020, Roche announced that it has acquired Stratos Genomics. The acquisition provides Roche access to Stratos Genomics unique chemistry, Sequencing by Expansion (SBX™).
In May 2019, Longas Technologies Pty Ltd emerges from stealth mode, unveiling its Morphoseq™ technology and announcing the appointment to CEO of Nick McCooke, who built and led the team at Solexa that pioneered NGS prior to the company being acquired by Illumina.


Key Target Audience
DNA Sequencing equipment manufacturers, vendors, and distributors, DNA Sequencing service companies, DNA Sequencing bioinformatics/data analysis companies, Research laboratories and academic institutes, Venture capitalists and other government funding organizations, Research and consulting firms and Pharmaceutical and biotechnology companies

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Consumable
  • Instrument
  • Service
By Application
  • Biomarkers and Cancer
  • Diagnostics
  • Reproductive Health
  • Personalized Medicine
  • Forensics
  • Research
  • Treatment analysis
By Technology
  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • Sequencing by Ligation
  • Pyrosequencing
  • Single-Molecule Real-time Sequencing
  • Chain Termination Sequencing
  • Nanopore Sequencing

By End User
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Hospitals & Clinics
  • Academic & Government Research Institutes

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Demand for Easy and Fast Clinical Diagnosis
      • 3.2.2. Increasing Number of Genome Mapping Programs
    • 3.3. Market Challenges
      • 3.3.1. Dearth of Skilled Professionals
    • 3.4. Market Trends
      • 3.4.1. Technological Advancements in DNA Sequencing
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global DNA Sequencing, by Type, Application, Technology, End User and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global DNA Sequencing (Value)
      • 5.2.1. Global DNA Sequencing by: Type (Value)
        • 5.2.1.1. Consumable
        • 5.2.1.2. Instrument
        • 5.2.1.3. Service
      • 5.2.2. Global DNA Sequencing by: Application (Value)
        • 5.2.2.1. Biomarkers and Cancer
        • 5.2.2.2. Diagnostics
        • 5.2.2.3. Reproductive Health
        • 5.2.2.4. Personalized Medicine
        • 5.2.2.5. Forensics
        • 5.2.2.6. Research
        • 5.2.2.7. Treatment analysis
      • 5.2.3. Global DNA Sequencing by: Technology (Value)
        • 5.2.3.1. Sequencing by Synthesis
        • 5.2.3.2. Ion Semiconductor Sequencing
        • 5.2.3.3. Sequencing by Ligation
        • 5.2.3.4. Pyrosequencing
        • 5.2.3.5. Single-Molecule Real-time Sequencing
        • 5.2.3.6. Chain Termination Sequencing
        • 5.2.3.7. Nanopore Sequencing
      • 5.2.4. Global DNA Sequencing by: End User (Value)
        • 5.2.4.1. Pharmaceutical Companies
        • 5.2.4.2. Biotechnology Companies
        • 5.2.4.3. Hospitals & Clinics
        • 5.2.4.4. Academic & Government Research Institutes
      • 5.2.5. Global DNA Sequencing Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. DNA Sequencing: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Siemens AG (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Pacific Biosciences of California, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Eppendorf (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. PerkinElmer, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Agilent Technologies, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Illumina, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. LI-COR Biosciences, Inc (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Oxford Nanopore Technologies Limited (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. F. Hoffmann-La Roche AG (Switzerland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. ThermoFisher Scientific (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Longas Technologies (Australia)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global DNA Sequencing Sale, by Type, Application, Technology, End User and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global DNA Sequencing (Value)
      • 7.2.1. Global DNA Sequencing by: Type (Value)
        • 7.2.1.1. Consumable
        • 7.2.1.2. Instrument
        • 7.2.1.3. Service
      • 7.2.2. Global DNA Sequencing by: Application (Value)
        • 7.2.2.1. Biomarkers and Cancer
        • 7.2.2.2. Diagnostics
        • 7.2.2.3. Reproductive Health
        • 7.2.2.4. Personalized Medicine
        • 7.2.2.5. Forensics
        • 7.2.2.6. Research
        • 7.2.2.7. Treatment analysis
      • 7.2.3. Global DNA Sequencing by: Technology (Value)
        • 7.2.3.1. Sequencing by Synthesis
        • 7.2.3.2. Ion Semiconductor Sequencing
        • 7.2.3.3. Sequencing by Ligation
        • 7.2.3.4. Pyrosequencing
        • 7.2.3.5. Single-Molecule Real-time Sequencing
        • 7.2.3.6. Chain Termination Sequencing
        • 7.2.3.7. Nanopore Sequencing
      • 7.2.4. Global DNA Sequencing by: End User (Value)
        • 7.2.4.1. Pharmaceutical Companies
        • 7.2.4.2. Biotechnology Companies
        • 7.2.4.3. Hospitals & Clinics
        • 7.2.4.4. Academic & Government Research Institutes
      • 7.2.5. Global DNA Sequencing Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. DNA Sequencing: by Type(USD Million)
  • Table 2. DNA Sequencing Consumable , by Region USD Million (2017-2022)
  • Table 3. DNA Sequencing Instrument , by Region USD Million (2017-2022)
  • Table 4. DNA Sequencing Service , by Region USD Million (2017-2022)
  • Table 5. DNA Sequencing: by Application(USD Million)
  • Table 6. DNA Sequencing Biomarkers and Cancer , by Region USD Million (2017-2022)
  • Table 7. DNA Sequencing Diagnostics , by Region USD Million (2017-2022)
  • Table 8. DNA Sequencing Reproductive Health , by Region USD Million (2017-2022)
  • Table 9. DNA Sequencing Personalized Medicine , by Region USD Million (2017-2022)
  • Table 10. DNA Sequencing Forensics , by Region USD Million (2017-2022)
  • Table 11. DNA Sequencing Research , by Region USD Million (2017-2022)
  • Table 12. DNA Sequencing Treatment analysis , by Region USD Million (2017-2022)
  • Table 13. DNA Sequencing: by Technology(USD Million)
  • Table 14. DNA Sequencing Sequencing by Synthesis , by Region USD Million (2017-2022)
  • Table 15. DNA Sequencing Ion Semiconductor Sequencing , by Region USD Million (2017-2022)
  • Table 16. DNA Sequencing Sequencing by Ligation , by Region USD Million (2017-2022)
  • Table 17. DNA Sequencing Pyrosequencing , by Region USD Million (2017-2022)
  • Table 18. DNA Sequencing Single-Molecule Real-time Sequencing , by Region USD Million (2017-2022)
  • Table 19. DNA Sequencing Chain Termination Sequencing , by Region USD Million (2017-2022)
  • Table 20. DNA Sequencing Nanopore Sequencing , by Region USD Million (2017-2022)
  • Table 21. DNA Sequencing: by End User(USD Million)
  • Table 22. DNA Sequencing Pharmaceutical Companies , by Region USD Million (2017-2022)
  • Table 23. DNA Sequencing Biotechnology Companies , by Region USD Million (2017-2022)
  • Table 24. DNA Sequencing Hospitals & Clinics , by Region USD Million (2017-2022)
  • Table 25. DNA Sequencing Academic & Government Research Institutes , by Region USD Million (2017-2022)
  • Table 26. South America DNA Sequencing, by Country USD Million (2017-2022)
  • Table 27. South America DNA Sequencing, by Type USD Million (2017-2022)
  • Table 28. South America DNA Sequencing, by Application USD Million (2017-2022)
  • Table 29. South America DNA Sequencing, by Technology USD Million (2017-2022)
  • Table 30. South America DNA Sequencing, by End User USD Million (2017-2022)
  • Table 31. Brazil DNA Sequencing, by Type USD Million (2017-2022)
  • Table 32. Brazil DNA Sequencing, by Application USD Million (2017-2022)
  • Table 33. Brazil DNA Sequencing, by Technology USD Million (2017-2022)
  • Table 34. Brazil DNA Sequencing, by End User USD Million (2017-2022)
  • Table 35. Argentina DNA Sequencing, by Type USD Million (2017-2022)
  • Table 36. Argentina DNA Sequencing, by Application USD Million (2017-2022)
  • Table 37. Argentina DNA Sequencing, by Technology USD Million (2017-2022)
  • Table 38. Argentina DNA Sequencing, by End User USD Million (2017-2022)
  • Table 39. Rest of South America DNA Sequencing, by Type USD Million (2017-2022)
  • Table 40. Rest of South America DNA Sequencing, by Application USD Million (2017-2022)
  • Table 41. Rest of South America DNA Sequencing, by Technology USD Million (2017-2022)
  • Table 42. Rest of South America DNA Sequencing, by End User USD Million (2017-2022)
  • Table 43. Asia Pacific DNA Sequencing, by Country USD Million (2017-2022)
  • Table 44. Asia Pacific DNA Sequencing, by Type USD Million (2017-2022)
  • Table 45. Asia Pacific DNA Sequencing, by Application USD Million (2017-2022)
  • Table 46. Asia Pacific DNA Sequencing, by Technology USD Million (2017-2022)
  • Table 47. Asia Pacific DNA Sequencing, by End User USD Million (2017-2022)
  • Table 48. China DNA Sequencing, by Type USD Million (2017-2022)
  • Table 49. China DNA Sequencing, by Application USD Million (2017-2022)
  • Table 50. China DNA Sequencing, by Technology USD Million (2017-2022)
  • Table 51. China DNA Sequencing, by End User USD Million (2017-2022)
  • Table 52. Japan DNA Sequencing, by Type USD Million (2017-2022)
  • Table 53. Japan DNA Sequencing, by Application USD Million (2017-2022)
  • Table 54. Japan DNA Sequencing, by Technology USD Million (2017-2022)
  • Table 55. Japan DNA Sequencing, by End User USD Million (2017-2022)
  • Table 56. India DNA Sequencing, by Type USD Million (2017-2022)
  • Table 57. India DNA Sequencing, by Application USD Million (2017-2022)
  • Table 58. India DNA Sequencing, by Technology USD Million (2017-2022)
  • Table 59. India DNA Sequencing, by End User USD Million (2017-2022)
  • Table 60. South Korea DNA Sequencing, by Type USD Million (2017-2022)
  • Table 61. South Korea DNA Sequencing, by Application USD Million (2017-2022)
  • Table 62. South Korea DNA Sequencing, by Technology USD Million (2017-2022)
  • Table 63. South Korea DNA Sequencing, by End User USD Million (2017-2022)
  • Table 64. Taiwan DNA Sequencing, by Type USD Million (2017-2022)
  • Table 65. Taiwan DNA Sequencing, by Application USD Million (2017-2022)
  • Table 66. Taiwan DNA Sequencing, by Technology USD Million (2017-2022)
  • Table 67. Taiwan DNA Sequencing, by End User USD Million (2017-2022)
  • Table 68. Australia DNA Sequencing, by Type USD Million (2017-2022)
  • Table 69. Australia DNA Sequencing, by Application USD Million (2017-2022)
  • Table 70. Australia DNA Sequencing, by Technology USD Million (2017-2022)
  • Table 71. Australia DNA Sequencing, by End User USD Million (2017-2022)
  • Table 72. Rest of Asia-Pacific DNA Sequencing, by Type USD Million (2017-2022)
  • Table 73. Rest of Asia-Pacific DNA Sequencing, by Application USD Million (2017-2022)
  • Table 74. Rest of Asia-Pacific DNA Sequencing, by Technology USD Million (2017-2022)
  • Table 75. Rest of Asia-Pacific DNA Sequencing, by End User USD Million (2017-2022)
  • Table 76. Europe DNA Sequencing, by Country USD Million (2017-2022)
  • Table 77. Europe DNA Sequencing, by Type USD Million (2017-2022)
  • Table 78. Europe DNA Sequencing, by Application USD Million (2017-2022)
  • Table 79. Europe DNA Sequencing, by Technology USD Million (2017-2022)
  • Table 80. Europe DNA Sequencing, by End User USD Million (2017-2022)
  • Table 81. Germany DNA Sequencing, by Type USD Million (2017-2022)
  • Table 82. Germany DNA Sequencing, by Application USD Million (2017-2022)
  • Table 83. Germany DNA Sequencing, by Technology USD Million (2017-2022)
  • Table 84. Germany DNA Sequencing, by End User USD Million (2017-2022)
  • Table 85. France DNA Sequencing, by Type USD Million (2017-2022)
  • Table 86. France DNA Sequencing, by Application USD Million (2017-2022)
  • Table 87. France DNA Sequencing, by Technology USD Million (2017-2022)
  • Table 88. France DNA Sequencing, by End User USD Million (2017-2022)
  • Table 89. Italy DNA Sequencing, by Type USD Million (2017-2022)
  • Table 90. Italy DNA Sequencing, by Application USD Million (2017-2022)
  • Table 91. Italy DNA Sequencing, by Technology USD Million (2017-2022)
  • Table 92. Italy DNA Sequencing, by End User USD Million (2017-2022)
  • Table 93. United Kingdom DNA Sequencing, by Type USD Million (2017-2022)
  • Table 94. United Kingdom DNA Sequencing, by Application USD Million (2017-2022)
  • Table 95. United Kingdom DNA Sequencing, by Technology USD Million (2017-2022)
  • Table 96. United Kingdom DNA Sequencing, by End User USD Million (2017-2022)
  • Table 97. Netherlands DNA Sequencing, by Type USD Million (2017-2022)
  • Table 98. Netherlands DNA Sequencing, by Application USD Million (2017-2022)
  • Table 99. Netherlands DNA Sequencing, by Technology USD Million (2017-2022)
  • Table 100. Netherlands DNA Sequencing, by End User USD Million (2017-2022)
  • Table 101. Rest of Europe DNA Sequencing, by Type USD Million (2017-2022)
  • Table 102. Rest of Europe DNA Sequencing, by Application USD Million (2017-2022)
  • Table 103. Rest of Europe DNA Sequencing, by Technology USD Million (2017-2022)
  • Table 104. Rest of Europe DNA Sequencing, by End User USD Million (2017-2022)
  • Table 105. MEA DNA Sequencing, by Country USD Million (2017-2022)
  • Table 106. MEA DNA Sequencing, by Type USD Million (2017-2022)
  • Table 107. MEA DNA Sequencing, by Application USD Million (2017-2022)
  • Table 108. MEA DNA Sequencing, by Technology USD Million (2017-2022)
  • Table 109. MEA DNA Sequencing, by End User USD Million (2017-2022)
  • Table 110. Middle East DNA Sequencing, by Type USD Million (2017-2022)
  • Table 111. Middle East DNA Sequencing, by Application USD Million (2017-2022)
  • Table 112. Middle East DNA Sequencing, by Technology USD Million (2017-2022)
  • Table 113. Middle East DNA Sequencing, by End User USD Million (2017-2022)
  • Table 114. Africa DNA Sequencing, by Type USD Million (2017-2022)
  • Table 115. Africa DNA Sequencing, by Application USD Million (2017-2022)
  • Table 116. Africa DNA Sequencing, by Technology USD Million (2017-2022)
  • Table 117. Africa DNA Sequencing, by End User USD Million (2017-2022)
  • Table 118. North America DNA Sequencing, by Country USD Million (2017-2022)
  • Table 119. North America DNA Sequencing, by Type USD Million (2017-2022)
  • Table 120. North America DNA Sequencing, by Application USD Million (2017-2022)
  • Table 121. North America DNA Sequencing, by Technology USD Million (2017-2022)
  • Table 122. North America DNA Sequencing, by End User USD Million (2017-2022)
  • Table 123. United States DNA Sequencing, by Type USD Million (2017-2022)
  • Table 124. United States DNA Sequencing, by Application USD Million (2017-2022)
  • Table 125. United States DNA Sequencing, by Technology USD Million (2017-2022)
  • Table 126. United States DNA Sequencing, by End User USD Million (2017-2022)
  • Table 127. Canada DNA Sequencing, by Type USD Million (2017-2022)
  • Table 128. Canada DNA Sequencing, by Application USD Million (2017-2022)
  • Table 129. Canada DNA Sequencing, by Technology USD Million (2017-2022)
  • Table 130. Canada DNA Sequencing, by End User USD Million (2017-2022)
  • Table 131. Mexico DNA Sequencing, by Type USD Million (2017-2022)
  • Table 132. Mexico DNA Sequencing, by Application USD Million (2017-2022)
  • Table 133. Mexico DNA Sequencing, by Technology USD Million (2017-2022)
  • Table 134. Mexico DNA Sequencing, by End User USD Million (2017-2022)
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Company Basic Information, Sales Area and Its Competitors
  • Table 145. Company Basic Information, Sales Area and Its Competitors
  • Table 146. DNA Sequencing: by Type(USD Million)
  • Table 147. DNA Sequencing Consumable , by Region USD Million (2023-2028)
  • Table 148. DNA Sequencing Instrument , by Region USD Million (2023-2028)
  • Table 149. DNA Sequencing Service , by Region USD Million (2023-2028)
  • Table 150. DNA Sequencing: by Application(USD Million)
  • Table 151. DNA Sequencing Biomarkers and Cancer , by Region USD Million (2023-2028)
  • Table 152. DNA Sequencing Diagnostics , by Region USD Million (2023-2028)
  • Table 153. DNA Sequencing Reproductive Health , by Region USD Million (2023-2028)
  • Table 154. DNA Sequencing Personalized Medicine , by Region USD Million (2023-2028)
  • Table 155. DNA Sequencing Forensics , by Region USD Million (2023-2028)
  • Table 156. DNA Sequencing Research , by Region USD Million (2023-2028)
  • Table 157. DNA Sequencing Treatment analysis , by Region USD Million (2023-2028)
  • Table 158. DNA Sequencing: by Technology(USD Million)
  • Table 159. DNA Sequencing Sequencing by Synthesis , by Region USD Million (2023-2028)
  • Table 160. DNA Sequencing Ion Semiconductor Sequencing , by Region USD Million (2023-2028)
  • Table 161. DNA Sequencing Sequencing by Ligation , by Region USD Million (2023-2028)
  • Table 162. DNA Sequencing Pyrosequencing , by Region USD Million (2023-2028)
  • Table 163. DNA Sequencing Single-Molecule Real-time Sequencing , by Region USD Million (2023-2028)
  • Table 164. DNA Sequencing Chain Termination Sequencing , by Region USD Million (2023-2028)
  • Table 165. DNA Sequencing Nanopore Sequencing , by Region USD Million (2023-2028)
  • Table 166. DNA Sequencing: by End User(USD Million)
  • Table 167. DNA Sequencing Pharmaceutical Companies , by Region USD Million (2023-2028)
  • Table 168. DNA Sequencing Biotechnology Companies , by Region USD Million (2023-2028)
  • Table 169. DNA Sequencing Hospitals & Clinics , by Region USD Million (2023-2028)
  • Table 170. DNA Sequencing Academic & Government Research Institutes , by Region USD Million (2023-2028)
  • Table 171. South America DNA Sequencing, by Country USD Million (2023-2028)
  • Table 172. South America DNA Sequencing, by Type USD Million (2023-2028)
  • Table 173. South America DNA Sequencing, by Application USD Million (2023-2028)
  • Table 174. South America DNA Sequencing, by Technology USD Million (2023-2028)
  • Table 175. South America DNA Sequencing, by End User USD Million (2023-2028)
  • Table 176. Brazil DNA Sequencing, by Type USD Million (2023-2028)
  • Table 177. Brazil DNA Sequencing, by Application USD Million (2023-2028)
  • Table 178. Brazil DNA Sequencing, by Technology USD Million (2023-2028)
  • Table 179. Brazil DNA Sequencing, by End User USD Million (2023-2028)
  • Table 180. Argentina DNA Sequencing, by Type USD Million (2023-2028)
  • Table 181. Argentina DNA Sequencing, by Application USD Million (2023-2028)
  • Table 182. Argentina DNA Sequencing, by Technology USD Million (2023-2028)
  • Table 183. Argentina DNA Sequencing, by End User USD Million (2023-2028)
  • Table 184. Rest of South America DNA Sequencing, by Type USD Million (2023-2028)
  • Table 185. Rest of South America DNA Sequencing, by Application USD Million (2023-2028)
  • Table 186. Rest of South America DNA Sequencing, by Technology USD Million (2023-2028)
  • Table 187. Rest of South America DNA Sequencing, by End User USD Million (2023-2028)
  • Table 188. Asia Pacific DNA Sequencing, by Country USD Million (2023-2028)
  • Table 189. Asia Pacific DNA Sequencing, by Type USD Million (2023-2028)
  • Table 190. Asia Pacific DNA Sequencing, by Application USD Million (2023-2028)
  • Table 191. Asia Pacific DNA Sequencing, by Technology USD Million (2023-2028)
  • Table 192. Asia Pacific DNA Sequencing, by End User USD Million (2023-2028)
  • Table 193. China DNA Sequencing, by Type USD Million (2023-2028)
  • Table 194. China DNA Sequencing, by Application USD Million (2023-2028)
  • Table 195. China DNA Sequencing, by Technology USD Million (2023-2028)
  • Table 196. China DNA Sequencing, by End User USD Million (2023-2028)
  • Table 197. Japan DNA Sequencing, by Type USD Million (2023-2028)
  • Table 198. Japan DNA Sequencing, by Application USD Million (2023-2028)
  • Table 199. Japan DNA Sequencing, by Technology USD Million (2023-2028)
  • Table 200. Japan DNA Sequencing, by End User USD Million (2023-2028)
  • Table 201. India DNA Sequencing, by Type USD Million (2023-2028)
  • Table 202. India DNA Sequencing, by Application USD Million (2023-2028)
  • Table 203. India DNA Sequencing, by Technology USD Million (2023-2028)
  • Table 204. India DNA Sequencing, by End User USD Million (2023-2028)
  • Table 205. South Korea DNA Sequencing, by Type USD Million (2023-2028)
  • Table 206. South Korea DNA Sequencing, by Application USD Million (2023-2028)
  • Table 207. South Korea DNA Sequencing, by Technology USD Million (2023-2028)
  • Table 208. South Korea DNA Sequencing, by End User USD Million (2023-2028)
  • Table 209. Taiwan DNA Sequencing, by Type USD Million (2023-2028)
  • Table 210. Taiwan DNA Sequencing, by Application USD Million (2023-2028)
  • Table 211. Taiwan DNA Sequencing, by Technology USD Million (2023-2028)
  • Table 212. Taiwan DNA Sequencing, by End User USD Million (2023-2028)
  • Table 213. Australia DNA Sequencing, by Type USD Million (2023-2028)
  • Table 214. Australia DNA Sequencing, by Application USD Million (2023-2028)
  • Table 215. Australia DNA Sequencing, by Technology USD Million (2023-2028)
  • Table 216. Australia DNA Sequencing, by End User USD Million (2023-2028)
  • Table 217. Rest of Asia-Pacific DNA Sequencing, by Type USD Million (2023-2028)
  • Table 218. Rest of Asia-Pacific DNA Sequencing, by Application USD Million (2023-2028)
  • Table 219. Rest of Asia-Pacific DNA Sequencing, by Technology USD Million (2023-2028)
  • Table 220. Rest of Asia-Pacific DNA Sequencing, by End User USD Million (2023-2028)
  • Table 221. Europe DNA Sequencing, by Country USD Million (2023-2028)
  • Table 222. Europe DNA Sequencing, by Type USD Million (2023-2028)
  • Table 223. Europe DNA Sequencing, by Application USD Million (2023-2028)
  • Table 224. Europe DNA Sequencing, by Technology USD Million (2023-2028)
  • Table 225. Europe DNA Sequencing, by End User USD Million (2023-2028)
  • Table 226. Germany DNA Sequencing, by Type USD Million (2023-2028)
  • Table 227. Germany DNA Sequencing, by Application USD Million (2023-2028)
  • Table 228. Germany DNA Sequencing, by Technology USD Million (2023-2028)
  • Table 229. Germany DNA Sequencing, by End User USD Million (2023-2028)
  • Table 230. France DNA Sequencing, by Type USD Million (2023-2028)
  • Table 231. France DNA Sequencing, by Application USD Million (2023-2028)
  • Table 232. France DNA Sequencing, by Technology USD Million (2023-2028)
  • Table 233. France DNA Sequencing, by End User USD Million (2023-2028)
  • Table 234. Italy DNA Sequencing, by Type USD Million (2023-2028)
  • Table 235. Italy DNA Sequencing, by Application USD Million (2023-2028)
  • Table 236. Italy DNA Sequencing, by Technology USD Million (2023-2028)
  • Table 237. Italy DNA Sequencing, by End User USD Million (2023-2028)
  • Table 238. United Kingdom DNA Sequencing, by Type USD Million (2023-2028)
  • Table 239. United Kingdom DNA Sequencing, by Application USD Million (2023-2028)
  • Table 240. United Kingdom DNA Sequencing, by Technology USD Million (2023-2028)
  • Table 241. United Kingdom DNA Sequencing, by End User USD Million (2023-2028)
  • Table 242. Netherlands DNA Sequencing, by Type USD Million (2023-2028)
  • Table 243. Netherlands DNA Sequencing, by Application USD Million (2023-2028)
  • Table 244. Netherlands DNA Sequencing, by Technology USD Million (2023-2028)
  • Table 245. Netherlands DNA Sequencing, by End User USD Million (2023-2028)
  • Table 246. Rest of Europe DNA Sequencing, by Type USD Million (2023-2028)
  • Table 247. Rest of Europe DNA Sequencing, by Application USD Million (2023-2028)
  • Table 248. Rest of Europe DNA Sequencing, by Technology USD Million (2023-2028)
  • Table 249. Rest of Europe DNA Sequencing, by End User USD Million (2023-2028)
  • Table 250. MEA DNA Sequencing, by Country USD Million (2023-2028)
  • Table 251. MEA DNA Sequencing, by Type USD Million (2023-2028)
  • Table 252. MEA DNA Sequencing, by Application USD Million (2023-2028)
  • Table 253. MEA DNA Sequencing, by Technology USD Million (2023-2028)
  • Table 254. MEA DNA Sequencing, by End User USD Million (2023-2028)
  • Table 255. Middle East DNA Sequencing, by Type USD Million (2023-2028)
  • Table 256. Middle East DNA Sequencing, by Application USD Million (2023-2028)
  • Table 257. Middle East DNA Sequencing, by Technology USD Million (2023-2028)
  • Table 258. Middle East DNA Sequencing, by End User USD Million (2023-2028)
  • Table 259. Africa DNA Sequencing, by Type USD Million (2023-2028)
  • Table 260. Africa DNA Sequencing, by Application USD Million (2023-2028)
  • Table 261. Africa DNA Sequencing, by Technology USD Million (2023-2028)
  • Table 262. Africa DNA Sequencing, by End User USD Million (2023-2028)
  • Table 263. North America DNA Sequencing, by Country USD Million (2023-2028)
  • Table 264. North America DNA Sequencing, by Type USD Million (2023-2028)
  • Table 265. North America DNA Sequencing, by Application USD Million (2023-2028)
  • Table 266. North America DNA Sequencing, by Technology USD Million (2023-2028)
  • Table 267. North America DNA Sequencing, by End User USD Million (2023-2028)
  • Table 268. United States DNA Sequencing, by Type USD Million (2023-2028)
  • Table 269. United States DNA Sequencing, by Application USD Million (2023-2028)
  • Table 270. United States DNA Sequencing, by Technology USD Million (2023-2028)
  • Table 271. United States DNA Sequencing, by End User USD Million (2023-2028)
  • Table 272. Canada DNA Sequencing, by Type USD Million (2023-2028)
  • Table 273. Canada DNA Sequencing, by Application USD Million (2023-2028)
  • Table 274. Canada DNA Sequencing, by Technology USD Million (2023-2028)
  • Table 275. Canada DNA Sequencing, by End User USD Million (2023-2028)
  • Table 276. Mexico DNA Sequencing, by Type USD Million (2023-2028)
  • Table 277. Mexico DNA Sequencing, by Application USD Million (2023-2028)
  • Table 278. Mexico DNA Sequencing, by Technology USD Million (2023-2028)
  • Table 279. Mexico DNA Sequencing, by End User USD Million (2023-2028)
  • Table 280. Research Programs/Design for This Report
  • Table 281. Key Data Information from Secondary Sources
  • Table 282. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global DNA Sequencing: by Type USD Million (2017-2022)
  • Figure 5. Global DNA Sequencing: by Application USD Million (2017-2022)
  • Figure 6. Global DNA Sequencing: by Technology USD Million (2017-2022)
  • Figure 7. Global DNA Sequencing: by End User USD Million (2017-2022)
  • Figure 8. South America DNA Sequencing Share (%), by Country
  • Figure 9. Asia Pacific DNA Sequencing Share (%), by Country
  • Figure 10. Europe DNA Sequencing Share (%), by Country
  • Figure 11. MEA DNA Sequencing Share (%), by Country
  • Figure 12. North America DNA Sequencing Share (%), by Country
  • Figure 13. Global DNA Sequencing share by Players 2022 (%)
  • Figure 14. Global DNA Sequencing share by Players (Top 3) 2022(%)
  • Figure 15. Global DNA Sequencing share by Players (Top 5) 2022(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Siemens AG (Germany) Revenue, Net Income and Gross profit
  • Figure 18. Siemens AG (Germany) Revenue: by Geography 2022
  • Figure 19. Pacific Biosciences of California, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. Pacific Biosciences of California, Inc. (United States) Revenue: by Geography 2022
  • Figure 21. Eppendorf (Germany) Revenue, Net Income and Gross profit
  • Figure 22. Eppendorf (Germany) Revenue: by Geography 2022
  • Figure 23. PerkinElmer, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. PerkinElmer, Inc. (United States) Revenue: by Geography 2022
  • Figure 25. Agilent Technologies, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Agilent Technologies, Inc. (United States) Revenue: by Geography 2022
  • Figure 27. Illumina, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Illumina, Inc. (United States) Revenue: by Geography 2022
  • Figure 29. LI-COR Biosciences, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 30. LI-COR Biosciences, Inc (United States) Revenue: by Geography 2022
  • Figure 31. Oxford Nanopore Technologies Limited (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 32. Oxford Nanopore Technologies Limited (United Kingdom) Revenue: by Geography 2022
  • Figure 33. F. Hoffmann-La Roche AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 34. F. Hoffmann-La Roche AG (Switzerland) Revenue: by Geography 2022
  • Figure 35. ThermoFisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 36. ThermoFisher Scientific (United States) Revenue: by Geography 2022
  • Figure 37. Longas Technologies (Australia) Revenue, Net Income and Gross profit
  • Figure 38. Longas Technologies (Australia) Revenue: by Geography 2022
  • Figure 39. Global DNA Sequencing: by Type USD Million (2023-2028)
  • Figure 40. Global DNA Sequencing: by Application USD Million (2023-2028)
  • Figure 41. Global DNA Sequencing: by Technology USD Million (2023-2028)
  • Figure 42. Global DNA Sequencing: by End User USD Million (2023-2028)
  • Figure 43. South America DNA Sequencing Share (%), by Country
  • Figure 44. Asia Pacific DNA Sequencing Share (%), by Country
  • Figure 45. Europe DNA Sequencing Share (%), by Country
  • Figure 46. MEA DNA Sequencing Share (%), by Country
  • Figure 47. North America DNA Sequencing Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Siemens AG (Germany)
  • Pacific Biosciences of California, Inc. (United States)
  • Eppendorf (Germany)
  • PerkinElmer, Inc. (United States)
  • Agilent Technologies, Inc. (United States)
  • Illumina, Inc. (United States)
  • LI-COR Biosciences, Inc (United States)
  • Oxford Nanopore Technologies Limited (United Kingdom)
  • F. Hoffmann-La Roche AG (Switzerland)
  • ThermoFisher Scientific (United States)
  • Longas Technologies (Australia)
Select User Access Type

Key Highlights of Report


Dec 2023 215 Pages 52 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global DNA Sequencing Quantitative research analysis
Global DNA Sequencing Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Siemens AG (Germany), Pacific Biosciences of California, Inc. (United States), Eppendorf (Germany), PerkinElmer, Inc. (United States), Agilent Technologies, Inc. (United States), Illumina, Inc. (United States), LI-COR Biosciences, Inc (United States), Oxford Nanopore Technologies Limited (United Kingdom), F. Hoffmann-La Roche AG (Switzerland), ThermoFisher Scientific (United States) and Longas Technologies (Australia) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Technological Advancements in DNA Sequencing" is seen as one of major influencing trends for DNA Sequencing Market during projected period 2022-2028.
The DNA Sequencing market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global DNA Sequencing Report?

Have a Query? Click Here

Other Related Reports

Agriculture Biotechnology Comprehensive Study by Type (Genome Editing Tools, Deoxy Ribonucleic Acid Sequencing, Ribonucleic Acid Interference, Synthetic Biology, Biochips), Application (Herbicide Tol...
$ 3800
Specific Pathogen Free Comprehensive Study by End Users (Research Institutes, Pharmaceutical Companies), Distribution Channels (Company Outlets, E-commerce Websites, Hypermarkets and Supermarkets, Po...
$ 3450
Polymers Drug Delivery Comprehensive Study by Type (Micelles, Microgels, Dendrimer, Hydrogels, Others), Application (Hospitals, Medical Research Center, Pharmaceutical Factory, Others), Formulations ...
$ 3650
Plant Activators Comprehensive Study by Type (Biological Plant Activators, Chemical Plant Activators), Application (Foliar Spray, Soil Treatment, Others), Forms (Solutions, Water-Dispersible & Water-...
$ 3450
Epithelial Stem Cells Comprehensive Study by Type (Absorptive Cells, Goblet Cell, Paneth Cells, Oligodendrocytes), Application (Tissue Repair Damage, Autoimmune Diseases, Others) Players and Region -...
$ 3500
Microbial Inoculants Comprehensive Study by Type (Agricultural Inoculants, Silage Inoculants), Crop Type (Oilseeds & Pulses, Cereals & Grains, Fruits & Vegetables, Forage), Microbes (Bacterial, Funga...
$ 3500